Familial chylomicronemia syndrome caused by compound heterozygous mutation of lipoprotein lipase gene: A case report and review of literature.

Clin Chim Acta

Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Department of Clinical Laboratory, the First Affiliated Hospital of Guangxi Medical University, Nanning 530021, Guangxi, China. Electronic address:

Published: December 2022

Familial chylomicronemia syndrome (FCS) caused by mutations of lipoprotein lipase (LPL) gene and other triglyceride-rich lipoprotein genes related with catabolism is an autosomal recessive rare disease. Herein, we report an infant with FCS and review the relevant literature. The proband is a male infant with FCS for which the whole-exome sequencing (WES), sanger sequencing and copy number variation (CNV) based on WES were performed. Compound heterozygous mutations (LPL gene c.1322+1G>C and loss in exons 8 to 10) were found in the LPL gene of the proband, the c.1322+1G>C mutation was inherited from his father with the heterozygous mutation, and the deletion of exons 8-10 due to CNVs was inherited from his mother. Carriers of heterozygous mutation or heterozygous deletion in LPL may have normal plasma lipids or develop FCS. Plasma lipids management of FCS in infancy should focus on the diet and adopt an individualized management.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cca.2022.10.001DOI Listing

Publication Analysis

Top Keywords

heterozygous mutation
12
lpl gene
12
familial chylomicronemia
8
chylomicronemia syndrome
8
compound heterozygous
8
lipoprotein lipase
8
infant fcs
8
plasma lipids
8
heterozygous
5
fcs
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!